About BillionToOne
BillionToOne is a company based in San Francisco (United States) founded in 2015 by Oguzhan Atay.. BillionToOne has raised $388.62 million across 10 funding rounds from investors including HHS, Baillie Gifford and Bridge Community Bank. The company has 47 employees as of December 31, 2020. BillionToOne offers products and services including UNITY Screen™, Northstar Select™, and Northstar Response™. BillionToOne operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter San Francisco, United States
- Employees 47 as on 31 Dec, 2020
- Founders Oguzhan Atay
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Billiontoone, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$388.62 M (USD)
in 10 rounds
-
Latest Funding Round
$130 M (USD), Series D
Jun 21, 2024
-
Investors
HHS
& 19 more
-
Employee Count
47
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BillionToOne
BillionToOne is a publicly listed company on the NASDAQ with ticker symbol BLLN in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BillionToOne
BillionToOne offers a comprehensive portfolio of products and services, including UNITY Screen™, Northstar Select™, and Northstar Response™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assesses fetal risk for recessive conditions and aneuploidies using maternal blood.
Determines appropriate first-line therapy for cancer patients.
Monitors effectiveness of cancer therapies through testing.
Unlock access to complete
Unlock access to complete
Funding Insights of BillionToOne
BillionToOne has successfully raised a total of $388.62M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $130 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $130.0M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Series D - BillionToOne | Valuation | Premji Invest | |
| Dec, 2022 | Amount | Series C - BillionToOne | Valuation | Baillie Gifford , Adams Street Partners | |
| Dec, 2022 | Amount | Debt – Conventional - BillionToOne | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BillionToOne
BillionToOne has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Baillie Gifford and Bridge Community Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides venture capital for technology startups and enterprise innovations worldwide.
|
Founded Year | Domain | Location | |
|
Secondary market fund focused on LP and direct secondary transactions
|
Founded Year | Domain | Location | |
|
Private markets investment management with strategies in equity, credit, and secondary investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BillionToOne
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BillionToOne
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Billiontoone Comparisons
Competitors of BillionToOne
BillionToOne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Billiontoone
Frequently Asked Questions about BillionToOne
When was BillionToOne founded?
BillionToOne was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is BillionToOne located?
BillionToOne is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of BillionToOne?
Oguzhan Atay is the current CEO of BillionToOne. They have also founded this company.
Is BillionToOne a funded company?
BillionToOne is a funded company, having raised a total of $388.62M across 10 funding rounds to date. The company's 1st funding round was a Series C of $48.5M, raised on Jun 01, 2017.
How many employees does BillionToOne have?
As of Dec 31, 2020, the latest employee count at BillionToOne is 47.
What does BillionToOne do?
BillionToOne was founded in 2015 in San Francisco, United States, within the biotechnology sector. Cell-free cancer liquid biopsy tests are offered, supported by a molecular counter platform that analyzes DNA molecules from blood samples. Additional genetic tests are provided for conditions including cystic fibrosis, spinal muscular atrophy, and sickle cell disease. Operations center on diagnostic services for oncology and inherited disorders.
Who are the top competitors of BillionToOne?
BillionToOne's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
What products or services does BillionToOne offer?
BillionToOne offers UNITY Screen™, Northstar Select™, and Northstar Response™.
Is BillionToOne publicly traded?
Yes, BillionToOne is publicly traded on NASDAQ under the ticker symbol BLLN.
Who are BillionToOne's investors?
BillionToOne has 20 investors. Key investors include HHS, Baillie Gifford, Bridge Community Bank, Neuberger Berman, and Norwest Venture Partners.
What is BillionToOne's ticker symbol?
The ticker symbol of BillionToOne is BLLN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.